Machine learning, neural networks help avoid human factor in healthcare. We are not saying that our healthcare will carry on without doctors, but doctors need to be saved from mundane work that can be done by machines — Elena Boyko, Deputy Minister of Health of the Russian Federation.
Change will help our teams of clinical doctors make more informed decisions and focus on things other than mundane work — Dan Vahdat, Co-Founder, Medopad.
Today, we are busy working on creating absolutely new vaccines against flu, hepatitis B and recombinant vaccines against immunodeficiencym. <…> I cannot but stress the role of the Academy in developing new diagnostics methods – first of all, in visualizing pathologies, microRNA methods. <…> Absolutely new approaches to individual therapy, and here I mainly mean genetic correction and editing — Vladimir Chekhonin, Vice President, Russian Academy of Sciences; Head of the Department of Medical Nanobiotechnology of Medical and Biological Faculty, N.I. Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation.
We have built robots which not only help gather large data volumes and use them in any moment in time. We can find new connections between diseases, their symptoms and treatments through the use of computer algorithms — Guzel Ulumbekova, President of the Board, Association of Medical Societies for Quality of Medical Care and Medical Education; Head, Higher School of Healthcare Organization and Management, MD.
Medicine is art, much like science. If we do not factor this in, whatever is being applied now will result in lots of side effects. Artificial intellect can never replace the doctor – it just assists — Grigory Roytberg, CEO of Medicina.
If we address management, requirements to a manager will not change in five years. A manager in a medical organization should understand what motivates the team and create this motivation — Igor Khatkov, Chief Non-Staff Specialist Oncologist, Moscow City Healthcare Department.
The Russian Academy of Science became the platform for the cross-agency council that is supposed to provide the scientific part of the country’s medications policy. The decision was driven by the fact that innovative medications are barely created in Russia — Vladimir Chekhonin, Vice President, Russian Academy of Sciences; Head of the Department of Medical Nanobiotechnology of Medical and Biological Faculty, N.I. Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation.
If we take our municipal clinics, where, unfortunately, the doctor is reduced to just several procedures, and all the knowledge they got at the university is automatically reduced. <…> This is how the soul and the responsibility are lost, if we fail to change the philosophy of the organization and tackle the general medical practice — Sergey Bagnenko, Rector, First Pavlov St. Petersburg State Medical University.
As treatment becomes more personalized and target medications are used more widely, we face the situation when diagnostic tests are applicable to smaller audience. <…> We face the situation when it is impossible to get a squadron of patience for statistically correct identification of the test sensitivity and specificity — Igor Korobko, Director of the Department of Science, Innovative Development and Management of Biomedical Health Risk at the Ministry of Health of the Russian Federation.
Borderlines between regions are fading. There is no tie between where people live and work or get medical assistance. The ratio between rural and urban dwellers is changing. Ageing of the population calls for new technologies — Nelli Naigovzina, Depurty Head, Analytical Center for the Government of the Russian Federation.
Another serious limitation we face is our doctors’ eduction. Their level of doctors’ education and training in our country is of course terrible and it is behind the requiments set by digitalization — Grigory Roytberg, CEO of Medicina.
Digital technologies are just a tool. <…> People whould own the responsibility for their health and kepping track of it. Digital technologies should provide the appropriate toolset, and here I mean mobile healthcare — Elena Boyko, Deputy Minister of Health of the Russian Federation.
One will be able to control and monitor their health, and this is how diseases will be diagnosed sooner. This is developing really fast — Julie Gerberding, Executive Vice President, Strategic Communications, Global Public Policy and Population Health, Chief Patient Officer, MSD.
Digital technologies need decision making and assessment systems developed. And digital technologies are precisely the tool that will help get rid of administrative barriers in healthcare, or in a single organization, or between organizations — Nelli Naigovzina, Depurty Head, Analytical Center for the Government of the Russian Federation.
Further medicine development lies above all in assisting with the way it uses information, in making it help the doctor and the patient. <…> Information needs to be stored somewhere and archived. It is a global problem. We realized we needed a vendor neutral archive that would be able to get information and archive it. Then both the doctor and the patient should be able to access it in such a way that they could use it. <…> We create applications that help doctors make the right decision — Nina Kandelaki, President and CEO of GE Healthcare in Russia and the CIS.
In order to introduce digital innovation, we need to change regulatory aspects for faster decision making when it comes to competent groups accessing depersonalized data — Natalya Polushkina, Vice President, Executive Director, Biomedical Cluster, Skolkovo Foundation.
Innovations are impossible in an isolated system. We need to create and develop international collaborations — Natalya Polushkina, Vice President, Executive Director, Biomedical Cluster, Skolkovo Foundation.
We need to develop the primary care. <…> We need to build a new model that will focus on preventing diseases and early dianostics. This will help reduce the number of severe stages — Armais Kamalov, Director, University Clinic, Lomonosov Moscow State University; Head of the Urology and Andrology Department, Faculty of Fundamental Medicine, Lomonosov Moscow State University.
There are issues that cannot be resolved single-handedly. They require cooperating with the government that must make decisions on prioritizing and supporting fundamental research — Julie Gerberding, Executive Vice President, Strategic Communications, Global Public Policy and Population Health, Chief Patient Officer, MSD.
A doctor must go through life-long training. Today, doctors need to absorb enormous amounts of information and keep studying — Arkadi Stolpner, Chairman of the Board, Sergey Berezin Medical Institute .